Current News

December 27, 2010: Vicus Therapeutics Announces Initiation of Phase 2 Trial to Evaluate VT-122 in Patients with Liver Cancer Receiving Nexavar.

December 21, 2011: Vicus Therapeutics to Present at Biotech Showcase, Wednesday, January 12, 2011 at 2:45pm PST.

Read More  

Breaking Research

 Oct 2, 2011: Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents. This is more content.

July 1, 2011: Beta blocker  associated with improved relapse free survival in triple negative breast cancer.

Vicus Therapeutics
55 Madison Avenue Suite 400
Morristown NJ 07960
(973) 285-3175
info@vicustherapeutics.com

Copyright © 2010 Vicus Therapeutics All Rights Reserved | Site Map | Privacy Policy